The substantial miss in both earnings per share and sales, coupled with a significant year-over-year decrease in sales, is likely to negatively impact investor sentiment and the stock price of Cellectis in the short term. The magnitude of the miss and the comparison to last year's performance highlight operational and possibly market challenges the company is facing, which could lead to decreased investor confidence.